Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CollPlant Biotechnologies (CLGN) Other Operating Expenses (2018 - 2019)

CollPlant Biotechnologies filings provide 2 years of Other Operating Expenses readings, the most recent being -$4.6 million for Q4 2019.

  • On a quarterly basis, Other Operating Expenses fell 2.24% to -$4.6 million in Q4 2019 year-over-year; TTM through Sep 2020 was -$4.6 million, a 2.01% increase, with the full-year FY2020 number at -$8.8 million, down 528.99% from a year prior.
  • Other Operating Expenses hit -$4.6 million in Q4 2019 for CollPlant Biotechnologies, down from -$75000.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $995000.0 in Q1 2018 to a low of -$4.6 million in Q4 2019.